This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Analysts' Actions: AAPL, VPHM, CVX

NEW YORK ( TheStreet) -- CHANGE IN RATINGS

Aegion (AEGN) upgraded to buy at TheStreet Ratings.

Apollo (APOL) downgraded at Deutsche from Buy to Hold, Deutsche Bank said. $45 price target. Company faces multiple growth headwinds.

Assured Guaranty (AGO) upgraded to buy at TheStreet Ratings.

Coinstar (CSTR) downgraded at JP Morgan from Overweight to Neutral, JP Morgan said. Valuation call, as the stock is up 35% year-to-date. $62 price target.

Cablevision (CVC) downgraded at Collins Stewart from Buy to Neutral, Collins Stewart. Growth will likely remain flat in the coming quarters.

Chevron (CVX - Get Report) upgraded at Deutsche from Hold to Buy, Deutsche Bank said. $130 price target. Valuation call, as the company is leveraged to higher Brent prices.

Domino's Pizza (DPZ) downgraded at JP Morgan from Overweight to Neutral, JP Morgan said. $38 price target. Valuation call, as the stock is up 143% since last January.

Ecolab (ECL) downgraded at JP Morgan from Overweight to Neutral, JP Morgan said. Valuation call, based on a $62 price target.

ITT Education (ESI) downgraded at Deutsche from Hold to Sell, Deutsche Bank said. $50 price target. Enrollment trends will likely slow down, as the labor market improves.

Ironwood Pharmaceuticals (IRWD) downgraded at Cantor to Sell, Cantor Fitzgerald said. Valuation call, based on a $10 price target.

Marathon Oil (MRO) downgraded at Deutsche from Buy to Hold, Deutsche Bank said. $37 price target. Taking a more defensive stance on oil sector.

Murphy Oil (MUR) downgraded at Deutsche from Buy to Hold, Deutsche Bank said. $64 price target. Company could be hurt by higher domestic oil supply.

Oasis Petroleum (OAS) downgraded at Deutsche from Buy to Hold, Deutsche Bank said. Higher oil prices could hurt demand. $37 price target.

MetroPCS (PCS) rated new Neutral at Nomura. $13 price target. Company is positioned relatively well, but the prepaid business faces multiple headwinds.

MetroPCS downgraded at UBS to Neutral from Buy, UBS said. $11 price target. Revised guidance suggests downside to 2012 estimates.

Thompson Creek (TC) downgraded at Dahlman from Buy to Hold, Dahlman Rose said. Costs at Mt. Milligan project are rising significantly.

Viropharma (VPHM - Get Report) downgraded at Auriga from Buy to Hold, Auriga USA said. Valuation call, based on a $34 price target.

1 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG
VPHM $49.96 -0.02%
AAPL $130.28 0.00%
CVX $109.87 0.00%
MSFT $47.87 0.00%
FB $81.53 0.00%

Markets

DOW 18,080.14 +21.45 0.12%
S&P 500 2,117.69 +4.76 0.23%
NASDAQ 5,092.0850 +36.0220 0.71%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs